Johnson & Johnson (JNJ) Insider Trading & Ownership $152.58 +0.17 (+0.11%) As of 03:58 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Johnson & Johnson (NYSE:JNJ) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.16%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$147.22KNumber OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$2.15M Get JNJ Insider Trade Alerts Want to know when executives and insiders are buying or selling Johnson & Johnson stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address JNJ Insider Buying and Selling by Quarter Johnson & Johnson Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/5/2025Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$155.01$1,001 - $15,0004/29/2025Gilbert Ray Cisneros, Jr.U.S. Congress Member (D-CA)Sell$155.90$1,001 - $15,0004/23/2025Ro KhannaU.S. Congress Member (D-CA)Buy$155.35$1,001 - $15,0004/21/2025Bruce WestermanU.S. Congress Member (R-AR)Sell$157.00$1,001 - $15,0004/9/2025Josh GottheimerU.S. Congress Member (D-NJ)Sell$149.02$1,001 - $15,0004/8/2025Robert Bresnahan, Jr.U.S. Congress Member (R-PA)Sell$149.24$1,001 - $15,0004/1/2025Julie JohnsonU.S. Congress Member (D-TX)Sell$153.25$1,001 - $15,0003/31/2025Gilbert Ray Cisneros, Jr.U.S. Congress Member (D-CA)Buy$165.89$15,001 - $50,0003/24/2025George WhitesidesU.S. Congress Member (D-CA)Sell$163.43$100,001 - $250,0003/7/2025Josh GottheimerU.S. Congress Member (D-NJ)Sell$166.81$1,001 - $15,0003/5/2025Jefferson ShreveU.S. Congress Member (R-IN)Buy$165.22$15,001 - $50,0003/4/2025Lloyd DoggettU.S. Congress Member (D-TX)Buy$165.48$1,001 - $15,0003/3/2025Bruce WestermanU.S. Congress Member (R-AR)Buy$167.08$1,001 - $15,0002/25/2025Robert J DeckerVPSell6,999$165.88$1,160,994.12 2/24/2025Jefferson ShreveU.S. Congress Member (R-IN)Buy$163.81$15,001 - $50,0002/18/2025Timothy SchmidEVPSell403$156.15$62,928.45 1/24/2025Gilbert Ray Cisneros, Jr.U.S. Congress Member (D-CA)Sell$146.76$1,001 - $15,0001/24/2025Josh GottheimerU.S. Congress Member (D-NJ)Buy$146.76$1,001 - $15,0001/21/2025Josh GottheimerU.S. Congress Member (D-NJ)Buy$148.10$1,001 - $15,0001/16/2025Josh GottheimerU.S. Congress Member (D-NJ)Buy$147.78$1,001 - $15,0001/8/2025Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$142.10$1,001 - $15,00012/31/2024Kevin HernU.S. Congress Member (R-OK)Sell$144.62$100,001 - $250,00012/24/2024Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$145.85$1,001 - $15,00012/12/2024Mark A WeinbergerDirectorBuy1,000$147.22$147,220.00 12/12/2024Josh GottheimerU.S. Congress Member (D-NJ)Buy$146.23$1,001 - $15,00012/10/2024Lloyd DoggettU.S. Congress Member (D-TX)Buy$149.26$1,001 - $15,00012/6/2024Virginia FoxxU.S. Congress Member (R-NC)Buy$149.28$1,001 - $15,00011/26/2024Josh GottheimerU.S. Congress Member (D-NJ)Buy$154.51$1,001 - $15,00011/25/2024Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$155.75$1,001 - $15,00011/22/2024Josh GottheimerU.S. Congress Member (D-NJ)Buy$155.14$1,001 - $15,00011/8/2024Jared MoskowitzU.S. Congress Member (D-FL)Buy$155.62$1,001 - $15,00010/29/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$160.14$15,001 - $50,0009/10/2024Lloyd DoggettU.S. Congress Member (D-TX)Buy$167.38$1,001 - $15,0009/4/2024John JamesU.S. Congress Member (R-MI)Sell$167.27$1,001 - $15,0008/30/2024Robert J DeckerVPSell5,635$165.06$930,113.10 (Data available from 1/1/2013 forward) JNJ Insider Trading Activity - Frequently Asked Questions Who is on Johnson & Johnson's Insider Roster? The list of insiders at Johnson & Johnson includes & Johnson Johnson, Ashley Mcevoy, James D Swanson, Jennifer L Taubert, Joseph J Wolk, Kathryn E Wengel, Mark A Weinberger, Peter Fasolo, Robert J Decker, Thibaut Mongon, Timothy Schmid, and William Hait. Learn more on insiders at JNJ. What percentage of Johnson & Johnson stock is owned by insiders? 0.16% of Johnson & Johnson stock is owned by insiders. Learn more on JNJ's insider holdings. Which Johnson & Johnson insiders have been buying company stock? The following insider purchased JNJ shares in the last 24 months: Mark A Weinberger ($147,220.00). How much insider buying is happening at Johnson & Johnson? Insiders have purchased a total of 1,000 JNJ shares in the last 24 months for a total of $147,220.00 bought. Which Johnson & Johnson insiders have been selling company stock? The following insiders have sold JNJ shares in the last 24 months: & Johnson Johnson ($96,142.25), Jennifer L Taubert ($9,281,969.19), Peter Fasolo ($3,406,400.00), Robert J Decker ($2,091,107.22), Timothy Schmid ($62,928.45), and William Hait ($2,528,056.00). How much insider selling is happening at Johnson & Johnson? Insiders have sold a total of 110,857 Johnson & Johnson shares in the last 24 months for a total of $17,466,603.11 sold. Which members of congress are trading Johnson & Johnson? Marjorie Taylor Greene (R-GA), Ro Khanna (D-CA), Gilbert Ray Cisneros, Jr. (D-CA), Jefferson Shreve (R-IN), Lloyd Doggett (D-TX), Bruce Westerman (R-AR), Josh Gottheimer (D-NJ), Virginia Foxx (R-NC), Jared Moskowitz (D-FL), C. Scott Franklin (R-FL), and Kathy E. Manning (D-NC) have bought shares of Johnson & Johnson in the last year totaling $290,000. Gilbert Ray Cisneros, Jr. (D-CA), Bruce Westerman (R-AR), Josh Gottheimer (D-NJ), Robert Bresnahan, Jr. (R-PA), Julie Johnson (D-TX), George Whitesides (D-CA), Kevin Hern (R-OK), Tommy Tuberville (R-AL), John James (R-MI), Rick W. Allen (R-GA), and Sheldon Whitehouse (D-RI) have sold shares totaling $511,500. Johnson & Johnson Key ExecutivesMr. Joaquin Duato (Age 61)CEO & Chairman Compensation: $6.21MDr. Peter M. Fasolo (Age 61)Executive VP & Chief Human Resources Officer Compensation: $2.15MMs. Jennifer L. Taubert (Age 60)Executive VP & Worldwide Chairman of Innovative Medicine Compensation: $3.1MDr. John C. Reed M.D. (Age 66)Ph.D., Executive Vice President of Innovative Medicine, R&D Compensation: $8.57MMr. Robert J. Decker Jr. (Age 52)Controller & Chief Accounting Officer 1 recent tradesMr. James Swanson (Age 58)Executive VP & Chief Information Officer Ms. Jessica MooreVice President of Investor RelationsMr. Dirk BrinckmanChief Compliance OfficerMs. Elizabeth Forminard (Age 53)Executive VP & Chief Legal Officer Dr. Guy J. Lebeau M.D.Group Chairman of MD&D Business - EMEA More Insider Trading Tools from MarketBeat Related Companies Eli Lilly and Company Insider Trading AbbVie Insider Trading Merck & Co., Inc. Insider Trading Pfizer Insider Trading Bristol Myers Squibb Insider Trading Zoetis Insider Trading Royalty Pharma Insider Trading Corcept Therapeutics Insider Trading Jazz Pharmaceuticals Insider Trading Perrigo Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors?Insiders Chase Income and Stability in American Tower—Here’s Why3 Tech Stocks With High and Rising Institutional Interest3 Summer Stocks With Insider Buying and Analyst Support This page (NYSE:JNJ) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Johnson & Johnson Please log in to your account or sign up in order to add this asset to your watchlist. Share Johnson & Johnson With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
